Dow Down 0.03% Nasdaq Up 0.31%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.95 Up 0.09(3.15%) 1:33PM EDT - Nasdaq Real Time Price
Prev Close:2.86
Open:2.97
Bid:2.96 x 1600
Ask:2.97 x 300
1y Target Est:10.17
Beta:1.18
Next Earnings Date:N/A
Day's Range:2.87 - 2.99
52wk Range:2.21 - 6.84
Volume:318,807
Avg Vol (3m):161,040
Market Cap:47.50M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIUp 3.15%47.50M
AGNUp 0.82%48.57B
ALNYUp 1.48%5.30B
MRNADown 5.22%27.93M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):284.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback